Quick Answer: Who Should Not Get Microneedling?

Microneedling is usually not recommended for people with active infection, open wounds, active inflammatory acne in the treatment area, flare-ups of rosacea, eczema or psoriasis, pregnancy or nursing, a history of keloid scarring, blood clotting disorders, immunosuppression, or recent isotretinoin use. Some situations are temporary, while others require medical clearance or a different treatment plan.

The safest answer is simple: do not self-clear yourself for treatment. A licensed provider should review your medical history, medications, skin condition, healing patterns, treatment goals, and state scope of practice requirements before beginning a microneedling session.

Why Contraindication Screening Matters

Professional microneedling works by creating controlled micro-injuries in the skin. That controlled response is what helps support collagen remodeling and visible improvement over a treatment series. The same mechanism also means the skin must be healthy enough to repair itself in a predictable way.

If a patient has an active skin condition, impaired healing, uncontrolled inflammation, or a medication history that changes how the skin repairs, treatment can create unnecessary risk. Screening is not a formality. It is the step that helps a provider decide whether to treat, delay, modify the treatment plan, or refer the patient for medical evaluation.

For clinics, contraindication screening also supports better documentation. A strong intake process connects the consultation, consent form, treatment notes, aftercare instructions, and follow-up plan. MDPen practitioners can build this into a repeatable workflow using resources such as the microneedling consent form checklist and professional training protocols.

Common Microneedling Contraindications

The list below is educational and should not replace medical judgment. Providers should always follow applicable state rules, their supervising medical director’s protocols, device instructions, and the patient’s individual health profile.

Active Infection or Open Skin

Microneedling should not be performed over active bacterial, viral, or fungal infections, open wounds, cuts, abrasions, or any skin that is visibly compromised. This includes active cold sores in or near the treatment area. Creating microchannels through infected or broken skin can increase the chance of spreading irritation or worsening the condition.

Patients should tell their provider about recent outbreaks, current lesions, or any area that feels tender, warm, swollen, or unusually irritated. In many cases, treatment can be rescheduled after the skin has fully healed and the provider confirms it is safe to proceed.

Active Inflammatory Acne in the Treatment Area

Microneedling may be used for certain types of acne scarring, but active inflammatory breakouts are different from old scars. Treating across inflamed pustules, cysts, or open acne lesions can irritate the area and may spread bacteria across the skin surface.

Patients with active acne may need a phased plan. The provider may first focus on calming inflammation, strengthening the barrier, and reducing active lesions before beginning a scar-focused treatment series. Once the skin is stable, professional microneedling may become part of a broader acne scar plan.

Rosacea, Eczema, Psoriasis, or Dermatitis Flare-Ups

Skin that is actively inflamed is more reactive. Rosacea flare-ups, eczema, psoriasis plaques, or dermatitis in the treatment zone may increase sensitivity and make healing less predictable. A provider may recommend waiting until the condition is controlled before performing microneedling.

Some patients with a history of inflammatory skin disease can still be candidates when symptoms are stable, but that decision should be made case by case. The treatment area, severity, current medications, and recent flare history all matter.

Pregnancy or Nursing

Many practices defer elective aesthetic microneedling during pregnancy and nursing. This conservative approach is often based on limited safety data for elective procedures, changing skin sensitivity, and the desire to avoid unnecessary risk during a temporary life stage.

Patients who are pregnant, trying to become pregnant, or nursing should disclose that information before scheduling treatment. A provider can explain the practice policy and recommend safer timing for future treatment planning.

History of Keloid Scarring or Abnormal Wound Healing

Because microneedling relies on a wound-healing response, a history of keloids or abnormal scarring deserves careful review. Keloids occur when scar tissue grows beyond the original injury site. Patients with this tendency may have a higher risk of an unwanted healing response after skin injury.

A provider may decline treatment, request medical clearance, or avoid certain areas depending on the patient’s history. Patients should mention any thick, raised, expanding, or itchy scars they have developed after piercings, acne, surgery, or injuries.

Blood Clotting Disorders or Bleeding Risk

Patients with blood clotting disorders, a history of unusual bleeding, or medications that affect clotting need individualized screening. Microneedling can cause pinpoint bleeding, and the provider must understand whether the patient’s health history changes the risk profile.

Patients should not stop prescribed medication just to receive an aesthetic treatment unless their prescribing clinician gives specific instructions. Instead, disclose all medications and supplements during intake so the provider can decide whether treatment should be delayed or medically cleared.

Immunosuppression or Serious Healing Concerns

Immunosuppression can affect the body’s ability to respond to controlled skin injury. This may include certain medical conditions, treatments, or medications. Patients undergoing cancer treatment, taking immune-modifying medication, or managing a condition that affects healing should discuss microneedling with their medical team before treatment.

Aesthetic practices should be especially careful with patients whose health status may increase infection risk or slow recovery. When in doubt, medical clearance is the safest path.

Recent Isotretinoin Use

Recent isotretinoin use is commonly treated as a contraindication or reason to delay microneedling. MDPen’s compliance framework notes recent isotretinoin use within 6 months as a screening concern. The exact waiting period may vary by provider protocol, medical director guidance, and patient factors.

Patients should tell their provider if they currently take isotretinoin or used it recently, even if their acne has improved. The provider can decide when the skin is ready for elective procedures.

Temporary Reasons to Delay Microneedling

Not every contraindication means a patient can never receive microneedling. Many concerns simply mean the appointment should be postponed until the skin or health situation is more stable.

This is where a year-round plan becomes useful. A structured microneedling treatment plan gives patients time to prepare the skin, schedule sessions around life events, and avoid rushing treatment when the skin is not ready.

Medication and Product Considerations Before Treatment

Patients should bring a full list of medications, supplements, topical prescriptions, recent procedures, and skincare products to the consultation. This includes acne medications, immune-related medications, blood thinners, exfoliating acids, retinoids, and any products that recently caused irritation.

Some products may need to be paused before treatment. Some medications may require medical clearance. Other products may be part of a pre-treatment plan to improve hydration and barrier support. The important point is transparency. A provider cannot screen well if the intake form is incomplete.

For practitioners: explore MDPen microneedling training for education on consultation flow, screening, protocols, and patient communication.

Who May Need Medical Clearance?

Medical clearance may be appropriate when a patient has a complex health history, uncertain diagnosis, healing concerns, or medication use that changes treatment risk. Examples include autoimmune disease, immune suppression, active cancer treatment, uncontrolled diabetes, bleeding disorders, or recent procedures that affect the treatment area.

Clearance does not guarantee treatment. It gives the provider more information so they can make a safer decision. Depending on the situation, the provider may still recommend waiting, choosing a gentler option, changing the treatment area, or declining treatment.

Patients should not view this as a rejection. It is part of responsible aesthetic care. The goal is not to treat everyone immediately. The goal is to treat the right patient, at the right time, with the right protocol.

How Practitioners Should Screen for Contraindications

A safe microneedling workflow starts before the patient enters the treatment room. Practices should use a consistent intake process that captures health history, medications, skin conditions, previous aesthetic treatments, scarring history, pregnancy or nursing status, allergies, and treatment goals.

A practical screening workflow may include:

• Reviewing the patient’s medical history and current medications.
• Asking about active skin conditions, infections, recent outbreaks, and healing problems.
• Evaluating the treatment area in person before selecting depth or technique.
• Documenting informed consent, realistic expectations, and aftercare instructions.
• Confirming that the provider is working within state scope of practice rules.
• Using sterile, single-use cartridges and proper infection control procedures.

MDPen’s practitioner ecosystem is built around this type of repeatable care. Professional devices, training, protocol education, and support materials help practices deliver microneedling with more consistency from consultation to follow-up.

Practitioners evaluating equipment and education can also review MDPen professional microneedling devices and pair device selection with appropriate training.

Patient Questions to Ask Before Booking

Patients do not need to become clinical experts before booking a consultation, but they should feel comfortable asking direct safety questions. Good providers welcome these conversations.

• Am I a good candidate for microneedling based on my skin and health history?
• Are any of my medications or skincare products a concern?
• Should I delay treatment because of a breakout, rash, recent procedure, or upcoming event?
• What aftercare instructions should I follow for the first 72 hours?
• What results are realistic for my concern and skin type?
• How many sessions might I need, and how will we adjust the plan if my skin reacts?

The answers should be specific to the patient. Generic promises, rushed consultations, or skipped intake forms are warning signs. Microneedling is common, but it is still a professional treatment that deserves professional screening.

How Contraindications Fit Into a Complete Treatment Plan

Contraindication screening is not separate from results. It is one of the reasons results are more predictable. When patients are screened carefully, providers can choose better timing, safer technique, appropriate aftercare, and a treatment series that respects the skin’s recovery cycle.

For acne scars, that may mean waiting until active acne is controlled. For pigment-prone skin, it may mean extra attention to pre-care and sun protection. For sensitive skin, it may mean a conservative first session and close follow-up. For practitioners, it may mean using the consent process to document why a patient was treated, delayed, or referred.

Ready to build a safer microneedling plan? Patients can find an MDPen practitioner, and providers can learn more about MDPen training.

Frequently Asked Questions About Microneedling Contraindications

Who is microneedling not suitable for?

Microneedling may not be suitable for people with active skin infection, open wounds, active inflammatory acne in the treatment area, inflammatory skin flare-ups, pregnancy or nursing, keloid history, blood clotting disorders, immunosuppression, or recent isotretinoin use. A licensed provider should make the final decision after screening.

Can I get microneedling if I have acne?

It depends on whether the acne is active and inflamed. Microneedling may help certain acne scars after breakouts are controlled, but providers usually avoid treating across active pustules, cysts, or open lesions. The skin may need to be stabilized first.

Can I get microneedling if I have lupus or an autoimmune condition?

Patients with lupus or another autoimmune condition should speak with their medical provider and the treating aesthetic provider before microneedling. Some conditions or medications may affect healing or infection risk, so medical clearance may be needed.

Is pregnancy a contraindication for microneedling?

Many practices defer elective microneedling during pregnancy and nursing. Patients should disclose pregnancy, plans to become pregnant, or nursing status before treatment so the provider can recommend the safest timing.

How long should I wait after isotretinoin before microneedling?

MDPen’s compliance framework flags recent isotretinoin use within 6 months as a screening concern. Waiting periods may vary by provider protocol and medical guidance, so patients should disclose current or recent isotretinoin use during intake.

Can microneedling be done over eczema or psoriasis?

Microneedling should not be performed over active eczema, psoriasis, dermatitis, or other inflamed skin in the treatment area. If the condition is stable, a provider can evaluate whether treatment is appropriate and whether medical guidance is needed.

The Bottom Line

Microneedling contraindications are not just a checklist. They are a safety framework that helps patients and practitioners decide when treatment is appropriate, when it should be delayed, and when medical input is needed. Active infection, inflamed skin, pregnancy or nursing, abnormal scarring history, bleeding concerns, immunosuppression, and recent isotretinoin use all deserve careful screening.

The best next step is a professional consultation. Patients should choose a trained provider who takes intake seriously. Practitioners should use education, documentation, and consistent protocols to support safer treatment decisions.